Matthias Grauert

This inventor holds 74 USPTO granted patents and 10 published patent applications, plus 13 CIPO patents and 27 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D). Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co Kg, Boehringer Ingelheim Kg. Active years: 1991-2019.

USPTO Granted Patents = 74 (Patent Applications = 10)

% Patents Active = 98.6

CIPO Patents = 13

EPO Patents = 27 (Patent Applications = 18)

Average Co-Inventor Count = 5.0

ph-index = 20

Forward Citations = 998(Granted Patents)

Forward Citations (Not Self Cited) = 802(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Ingelheim am Rhein, DE (1991 - 2002)
Ingelheim, DE (1999 - 2002)
Biberach, DE (2004 - 2013)
Biberach an der Riss, DE (2014 - 2019)

Company Filing History:

47 out of 1,560

Boehringer Ingelheim International Gmbh

patents

10 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

8 out of 197

Boehringer Ingelheim Kg

patents

4. 8 out of 149

Boehringer Ingelheim Pharma Kg

patents

5. 1 out of 306

Boehringer Ingelheim Gmbh

patents

Years Active: 1991-2019

Loading Chart...

Areas of Expertise:

Spirocycles

Aza-bicyclo Compounds

Cathepsin C Inhibitors

Fibrotic Diseases

mGlu5 Receptor Modulators

PI3-Kinase Inhibitors

Dihydropteridione Derivatives

Bronchodilators

Piperazine Derivatives

Thiazolyl Compounds

Benzoxazole Agonists

Triazoles

74 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE47636 - Substituted spirocycles (2019-10-07),

2. 10238633 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2019-03-26),

3. 10154990 - Medicaments for the treatment or prevention of fibrotic diseases (2018-12-18),

4. 9879026 - Substituted spirocycles (2018-01-30),

5. 9713606 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2017-07-25),

6. 9540373 - Substituted spirocycles (2017-01-10),

7. 9440960 - Substituted oxetanes and their use as inhibitors of cathepsin C (2016-09-13),

8. 9243000 - Thia-triaza-indacenes (2016-01-26),

9. 9073869 - Method of using substituted 2-Aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2015-07-07),

10. 8987249 - Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C (2015-03-24),

11. 8937176 - Compounds (2015-01-20),

12. 8889708 - Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2014-11-18),

13. 8889677 - Substituted triazoles useful as mGlu5 receptor modulators (2014-11-18),

14. 8877775 - Substituted 2-aza-bicyclo[2.2.2]octane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C (2014-11-04),

15. 8846948 - Compounds (2014-09-30),

Title: The Innovative Mind of Matthias Grauert

Introduction: Matthias Grauert is a pioneering inventor hailing from Biberach, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Matthias Grauert holds several patents in the areas of renewable energy technologies, smart devices, and advanced manufacturing processes, showcasing his continuous dedication to pushing the boundaries of innovation.

Career Highlights: With a career spanning over two decades, Matthias Grauert has worked tirelessly to transform his inventive ideas into tangible solutions that have the potential to revolutionize industries and improve the quality of life for many.

Collaborations: Throughout his career, Matthias Grauert has collaborated with leading research institutions, universities, and innovative companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Matthias Grauert's passion for innovation, coupled with his relentless drive to create solutions that make a difference, solidifies his position as a visionary inventor shaping the future of technology and beyond.